Details for Patent: 9,750,711
✉ Email this page to a colleague
Which drugs does patent 9,750,711 protect, and when does it expire?
Patent 9,750,711 protects ABSORICA LD and is included in one NDA.
This patent has eight patent family members in eight countries.
Summary for Patent: 9,750,711
| Title: | Low dose oral pharmaceutical composition of isotretinoin |
| Abstract: | The present invention provides a low dose oral pharmaceutical composition of isotretinoin having reduced food effect, in particular no food effect. The present invention further relates to a process for preparing the oral pharmaceutical composition of the present invention. |
| Inventor(s): | Madan; Harish Kumar (Haryana, IN), Venkateshwaran; Rathinasabapathy (Tamil Nadu, IN), Madan; Sumit (Delhi, IN), Kochhar; Ravi (Haryana, IN) |
| Assignee: | Sun Pharmaceutical Industries Limited (Mumbai, IN) |
| Application Number: | 15/444,571 |
|
Patent Claim Types: see list of patent claims | Composition; Formulation; Device; Dosage form; |
Drugs Protected by US Patent 9,750,711
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Patented / Exclusive Use | Submissiondate |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sun Pharm | ABSORICA LD | isotretinoin | CAPSULE;ORAL | 211913-001 | Nov 5, 2019 | RX | Yes | No | ⤷ Try a Trial | ⤷ Try a Trial | Y | ⤷ Try a Trial | ||||
| Sun Pharm | ABSORICA LD | isotretinoin | CAPSULE;ORAL | 211913-002 | Nov 5, 2019 | RX | Yes | No | ⤷ Try a Trial | ⤷ Try a Trial | Y | ⤷ Try a Trial | ||||
| Sun Pharm | ABSORICA LD | isotretinoin | CAPSULE;ORAL | 211913-003 | Nov 5, 2019 | DISCN | Yes | No | ⤷ Try a Trial | ⤷ Try a Trial | Y | ⤷ Try a Trial | ||||
| Sun Pharm | ABSORICA LD | isotretinoin | CAPSULE;ORAL | 211913-004 | Nov 5, 2019 | RX | Yes | No | ⤷ Try a Trial | ⤷ Try a Trial | Y | ⤷ Try a Trial | ||||
| Sun Pharm | ABSORICA LD | isotretinoin | CAPSULE;ORAL | 211913-005 | Nov 5, 2019 | DISCN | Yes | No | ⤷ Try a Trial | ⤷ Try a Trial | Y | ⤷ Try a Trial | ||||
| Sun Pharm | ABSORICA LD | isotretinoin | CAPSULE;ORAL | 211913-006 | Nov 5, 2019 | RX | Yes | Yes | ⤷ Try a Trial | ⤷ Try a Trial | Y | ⤷ Try a Trial | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Patented / Exclusive Use | >Submissiondate |
Foreign Priority and PCT Information for Patent: 9,750,711
| Foriegn Application Priority Data | ||
| Foreign Country | Foreign Patent Number | Foreign Patent Date |
| India | 2827/DEL/2014 | Oct 1, 2014 |
International Family Members for US Patent 9,750,711
| Country | Patent Number | Estimated Expiration | Supplementary Protection Certificate | SPC Country | SPC Expiration |
|---|---|---|---|---|---|
| Australia | 2015326489 | ⤷ Try a Trial | |||
| Brazil | 112017006779 | ⤷ Try a Trial | |||
| Canada | 2963206 | ⤷ Try a Trial | |||
| European Patent Office | 3200877 | ⤷ Try a Trial | |||
| Japan | 2017530149 | ⤷ Try a Trial | |||
| Mexico | 2017004312 | ⤷ Try a Trial | |||
| Russian Federation | 2017114924 | ⤷ Try a Trial | |||
| >Country | >Patent Number | >Estimated Expiration | >Supplementary Protection Certificate | >SPC Country | >SPC Expiration |
